Finished
Feasibility of RUS Lung in MITS
NCT06952894 · Hutom Corp · Updated 3 Sept 2025
- What is being tested
- RUS Lung
- For
- Lung Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years and older. About 34 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 12 May 2025, ends 11 Aug 2025. Registered 1 May 2025.
- Results
- None posted yet.
In the researchers' words
This sponsor-initiated prospective observational study aims to demonstrate the feasibility and efficacy of RUS Lung Surgical Navigation System in patients undergoing minimally invasive thoracic surgery(MITS). The trial will enroll 36 patients who undergo video-assisted or robot-assisted thoracoscopic surgery using RUS Lung. The study will be conducted across two medical centers." * Investigational Medical Device: RUS Lung (Endoscopic Imaging Treatment Planning Software) * Clinical Trial duration: 12 months from IRB approval * Target number of subjects: Total of 36 participants
Sites
- Severance HospitalSeoul, South Korea